Cov


Journal

Analytical chemistry
ISSN: 1520-6882
Titre abrégé: Anal Chem
Pays: United States
ID NLM: 0370536

Informations de publication

Date de publication:
20 12 2022
Historique:
pubmed: 10 12 2022
medline: 22 12 2022
entrez: 9 12 2022
Statut: ppublish

Résumé

The pandemic readiness toolbox needs to be extended, targeting different biomolecules, using orthogonal experimental set-ups. Here, we build on our Cov-MS effort using LC-MS, adding SISCAPA technology to enrich proteotypic peptides of the SARS-CoV-2 nucleocapsid (N) protein from trypsin-digested patient samples. The Cov

Identifiants

pubmed: 36490367
doi: 10.1021/acs.analchem.2c01610
pmc: PMC9773173
doi:

Substances chimiques

Peptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17379-17387

Subventions

Organisme : Medical Research Council
ID : MC_PC_18054
Pays : United Kingdom

Références

Front Cell Infect Microbiol. 2021 Oct 13;11:765039
pubmed: 34722346
EMBO Mol Med. 2022 Feb 7;14(2):e15290
pubmed: 34862752
Clin Chem. 2021 Dec 30;68(1):153-162
pubmed: 34633030
Clin Proteomics. 2021 Oct 22;18(1):25
pubmed: 34686148
Proteomics. 2018 Dec;18(24):e1800186
pubmed: 30387297
PLoS Biol. 2021 Jul 12;19(7):e3001333
pubmed: 34252080
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32414838
PLoS Comput Biol. 2021 Mar 9;17(3):e1008688
pubmed: 33690626
Elife. 2021 Nov 08;10:
pubmed: 34747696
J Proteome Res. 2016 Dec 2;15(12):4763-4769
pubmed: 27700092
N Engl J Med. 2020 Jun 4;382(23):2261-2264
pubmed: 32433861
PLoS One. 2021 Nov 11;16(11):e0259165
pubmed: 34762662
Vaccine. 2009 Oct 23;27(45):6363-5
pubmed: 19840674
Anal Bioanal Chem. 2021 Nov;413(26):6503-6511
pubmed: 34427712
J Proteome Res. 2020 Nov 6;19(11):4393-4397
pubmed: 32786682
ACS Omega. 2021 Dec 07;6(50):34945-34953
pubmed: 34926968
J Proteins Proteom. 2020;11(3):159-165
pubmed: 33132628
Lancet. 2021 Jan 2;397(10268):24-25
pubmed: 33333002
Cell. 2020 Oct 29;183(3):730-738.e13
pubmed: 32979942
Am J Clin Pathol. 2022 May 4;157(5):731-741
pubmed: 34724038
J Proteome Res. 2020 Nov 6;19(11):4407-4416
pubmed: 32697082
Int J Infect Dis. 2021 Jan;102:299-302
pubmed: 33130202
J Proteome Res. 2004 Mar-Apr;3(2):235-44
pubmed: 15113099
JACS Au. 2021 Jun 28;1(6):750-765
pubmed: 34254058
N Engl J Med. 2020 Nov 26;383(22):e120
pubmed: 32997903
Nat Commun. 2020 Dec 3;11(1):6201
pubmed: 33273458
Nucleic Acids Res. 2020 Jan 8;48(D1):D1145-D1152
pubmed: 31686107
Mol Cell Proteomics. 2020 Sep;19(9):1503-1522
pubmed: 32591346
Proteomics. 2020 Jul;20(14):e2000107
pubmed: 32462744
J Proteome Res. 2020 Nov 6;19(11):4389-4392
pubmed: 32568543
J Proteome Res. 2021 Feb 5;20(2):1434-1443
pubmed: 33497234
Bioanalysis. 2020 Jul;12(13):937-955
pubmed: 32253915
Elife. 2021 Dec 10;10:
pubmed: 34889738

Auteurs

Bart Van Puyvelde (B)

ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium.

Katleen Van Uytfanghe (K)

Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium.

Laurence Van Oudenhove (L)

Waters Corporation, 2600 Antwerp, Belgium.

Ralf Gabriels (R)

VIB-UGent Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.

Tessa Van Royen (T)

VIB-UGent Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium.
Department of Biochemistry and Microbiology, Ghent University, Ghent 9000 Belgium.

Arne Matthys (A)

VIB-UGent Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium.
Department of Biochemistry and Microbiology, Ghent University, Ghent 9000 Belgium.

Morteza Razavi (M)

SISCAPA Assay Technologies, Inc., Box 53309, Washington, DC 20009, United States.
Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada.

Richard Yip (R)

SISCAPA Assay Technologies, Inc., Box 53309, Washington, DC 20009, United States.
Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada.

Terry Pearson (T)

SISCAPA Assay Technologies, Inc., Box 53309, Washington, DC 20009, United States.
Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada.

Nicolas Drouin (N)

Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2333 AL Leiden, The Netherlands.

Jan Claereboudt (J)

Waters Corporation, 2600 Antwerp, Belgium.

Dominic Foley (D)

Waters Corporation, Wilmslow SK9 4AX, United Kingdom.
Waters Corporation, Milford, Massachusetts 01757, United States.

Robert Wardle (R)

Waters Corporation, Wilmslow SK9 4AX, United Kingdom.
Waters Corporation, Milford, Massachusetts 01757, United States.

Kevin Wyndham (K)

Waters Corporation, Wilmslow SK9 4AX, United Kingdom.
Waters Corporation, Milford, Massachusetts 01757, United States.

Thomas Hankemeier (T)

Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2333 AL Leiden, The Netherlands.

Donald Jones (D)

Leicester Cancer Research Centre, RKCSB, Cardiovascular Research Centre, Glenfield Hospital, University of Leicester, Leicester LE1 7RH, United Kingdom.
John and Lucille van Geest Biomarker Facility, Leicester LE3 9QP, United Kingdom.
The Department of Chemical Pathology and Metabolic Diseases, Leicester Royal Infirmary, Level 4, Sandringham Building, Leicester LE1 7RH, United Kingdom.

Xavier Saelens (X)

VIB-UGent Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium.
Department of Biochemistry and Microbiology, Ghent University, Ghent 9000 Belgium.

Geert Martens (G)

AZ Delta Medical Laboratories, AZ Delta General Hospital, 8800 Roeselare, Belgium.

Christophe P Stove (CP)

Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium.

Dieter Deforce (D)

ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium.

Lennart Martens (L)

VIB-UGent Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.

Johannes P C Vissers (JPC)

Waters Corporation, Wilmslow SK9 4AX, United Kingdom.
Waters Corporation, Milford, Massachusetts 01757, United States.

N Leigh Anderson (NL)

SISCAPA Assay Technologies, Inc., Box 53309, Washington, DC 20009, United States.

Maarten Dhaenens (M)

ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH